Data-Driven Drug Development: Accelerating Small Molecule Success in Early Phase

The development of small-molecule therapeutics has never been more complex. Pharmaceutical researchers are faced with molecules with higher molecular weight and increasing 3D character. At the same time, regulatory expectations are rising, market competition is intensifying, and patient needs demand more rapid development timelines. In this context, leveraging early-phase, data-driven strategies is essential for accelerating drug development while mitigating risk.

LATEST VIDEO

Latest news

14th January 2026

Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals

14th January 2026

Bayer Acquires Investigational Imaging Agents from Attralus

14th January 2026

Sartorius expands bio-circular product offering for more sustainable bioprocesses

14th January 2026

Symeres welcomes Jurgen Berendsen as Chief Financial Officer to support next phase of growth

13th January 2026

HAS Healthcare Advanced Synthesis SA Group Announces Strategic Investment Plan to Strengthen Leadership in CDMO and ADC Manufacturing

13th January 2026

Astoriom Appoints Will Edwards as Chief Executive Officer

13th January 2026

Optibrium Appoints Dr Nathan Brown as Director of Science

12th January 2026

AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States

12th January 2026

Bio-Sourcing and Zerion Pharma join forces to develop first HER2 oral monoclonal antibody against breast cancer

12th January 2026

Hongene Biotech Announces Grant to Expand Global Access to mRNA Vaccine Raw Materials

12th January 2026

Jubilant Biosys Doubles Early Chemistry Scale-up Capacity with New Noida Facility in India

This week’s featured articles

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Axplora: Mastering complexity

Large Language Models and Beyond: AI’s Impact on Clinical Trial Efficiency and Integrity

Why innovator companies need to take control of their supply chains

Partnered with top industry events and organisations